Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Flexible Forward Scatter Technology Enables Advances

Published: Thursday, May 01, 2014
Last Updated: Tuesday, May 06, 2014
Bookmark and Share
MoFlo® Astrios EQ from Beckman Coulter Life Sciences Delivers Simultaneous High-speed Cell Sorting and Sub-micron Particle Detection.

The six-way jet-in-air sorter from Beckman Coulter Life Sciences, delivers patent pending enhanced dual forward scatter (eFSC) technology for simultaneous sorting and detection of particles from 200 nm to 30 µm in diameter.  The instrument sets a new standard for flow cytometry core facilities, delivering high-speed cell sorting and micro-particle detection in a single package.  Featuring detailed and precise forward scatter resolution, beadless drop sample handling and increased biosafety, Astrios EQ meets a range of analysis needs.  

Intellisort II, the world’s first and only beadless drop-delay technology , eliminates the need for bead-based drop-delay routines.  This alleviates the requirement to remove sterile samples during drop-delay recalculation due to nozzle blockages and ensures uninterrupted sort sterility.  Intellisort II’s ability to maintain droplet breakoff for uninterrupted aseptic sorting helps to preserve sort integrity.  

A broad standard laser palette provides more wavelength choices than is found in most standard cuvette-based systems.  In fully configured instruments, users can reduce compensation requirements through the use of up to seven spatially separated lasers across 32 parameters simultaneously (out of a palette of 51 parameters).  Six of seven laser choices can be configured as the primary laser used in eFSC detection.  Dual eFSC permits measurement of scatter characteristics across three orders of magnitude simultaneously.  Choice of wavelength extends eFSC detection within 405-640 nm, allowing small and large particle detection.

Researchers can work with a great range of biological samples, analysing and sorting cells from microsomes to macrophages, from astrocytes to xenografts. Examples of non-biological applications could include agarose gel droplets, gold nanoparticles or environmental particulates.  Single-cell applications include circulating tumor cells, drug discovery, rare event analysis, stem and neuronal cells and ecological and physiological microbes.

“By combining high-speed sorting and micro-particle detection in a single package, the MoFlo Astrios EQ will be tremendously useful to the flow cytometry core facility,” said Mario Koksch, vice president and general manager of the Cytometry Business Unit for Beckman Coulter Life Sciences.  “Researchers should find its spectrum of sample-handling, multi-laser options, beadless drop delay and enhanced forward scatter technology make for a powerful and flexible instrument.”

An optional Baker Company SterilGARD® Class II biological safety cabinet can be fully integrated with the MoFlo Astrios EQ to provide assured biological safety.  An auto-quality control function monitors sheath pressure, sample pressure, average event rate, start and end times, nozzle size, differential between measured parameters and pass/fail thresholds.  Summit 6.2.2 software allows acquisition and storage of over one billion events, across multiple parameters, while sorting.  Astrios EQ accommodates currently available plate and slide-based sorting options, including standard and custom formats.  


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Beckman To Acquire Cytometer Developer Xitogen
Acquisition will broaden product offering, providing an Asian operations centre.
Wednesday, April 23, 2014
Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!